Institute of Science Tokyo · Graduate School of Medical and Dental Sciences · 教授

Research keywords化学療法誘発末梢神経障害・POEMS症候群・CIDP・多巣性運動ニューロパチー・Guillain-Barré症候群・ALS診断基準・抗MAGニューロパチー・フローサイトメトリー

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Mishina T, Ohwada C, Suichi T, Matsui S, Ishii A, Takaishi K, Oshima-Hasegawa N, Tsukamoto S, Takeda Y, Misawa S, Mimura N, Kuwabara S, Nakaseko C, Sakaida E. Clinical Impact of Osteolytic Bone Lesions in POEMS Syndrome: A Single-Center Experience of 114 Patients. Hematological oncology. 2025.01; 43 (1): e70037. ( PubMed , DOI )2025
• Nara T, Shibuya K, Ikeda S, Kuroiwa R, Otani R, Ogushi M, Suichi T, Shiko Y, Takahashi K, Misawa S, Murata A, Kuwabara S. Different patterns of fasciculation in spinal and bulbar muscular atrophy and amyotrophic lateral sclerosis: a muscle ultrasonographic study. BMJ neurology open. 2025; 7 (1): e001065. ( PubMed , DOI )2025
• 関口 縁, 三澤 園子. 【病状説明update-協働意思決定,性差医療,新規治療】慢性炎症性脱髄性多発根ニューロパチー(CIDP)における病状説明 BRAIN and NERVE: 神経研究の進歩. 2025.03; 77 (3): 0239-0243. ( 医中誌 )2025
• Suichi T, Misawa S, Shibuya K, Morooka M, Ogushi M, Oshima-Hasegawa N, Tsukamoto S, Takeda Y, Mimura N, Sakaida E, Kuwabara S. Daratumumab (anti-CD38)- and elotuzumab (anti-SLAMF7)-based treatments for refractory POEMS syndrome: a single-center case series. Hematology (Amsterdam, Netherlands). 2025.12; 30 (1): 2519896. ( PubMed , DOI )2025